Insmed Stock Forecast

Stock Price Forecast

According to 23 analysts polled by S&P Global, Insmed stock has a consensus rating of "Strong Buy" and an average price target of $196.18. The average 1-year stock price forecast is 93.30% higher than the current stock price, while the lowest is $140 (+37.94%) and the highest is $243 (+139.43%).

Price Target: $196.18 (+93.30%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$140	$196.18	$197.5	$243
Change	+37.94%	+93.30%	+94.60%	+139.43%

Analyst Ratings

The average analyst rating for Insmed stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Feb '26	Mar '26	Apr '26	May '26	Jun '26	Jul '26
Strong Buy	17	17	17	17	17	18
Buy	2	3	4	5	5	5
Hold	1	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	20	20	21	22	22	23

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Olivia Brayer Cantor Fitzgerald	Cantor Fitzgerald	Buy Maintains $235	Buy	Maintains	$235	+131.55%	Jul 28, 2026
Maxwell Skor Morgan Stanley	Morgan Stanley	Buy Maintains $212	Buy	Maintains	$212	+108.89%	Jul 23, 2026
Jessica Fye J.P. Morgan	J.P. Morgan	Buy Reiterates $179	Buy	Reiterates	$179	+76.37%	Jul 22, 2026
Vamil Divan Guggenheim	Guggenheim	Buy Maintains $207	Buy	Maintains	$207	+103.96%	Jul 21, 2026
Ritu Baral TD Cowen	TD Cowen	Buy Maintains $200 → $243	Buy	Maintains	$200 → $243	+139.43%	Jul 21, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.70B

from 606.42M

180.47%

from 606.42M

Revenue Next Year

2.78B

from 1.70B

63.23%

from 1.70B

EPS This Year

-2.59

from -6.42

EPS Next Year

0.13

from -2.59

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	188.46M	245.36M	305.21M	363.71M	606.42M	1.70B
Revenue Growth	14.63%	30.19%	24.39%	19.17%	66.73%	180.47%
Gross Profit	144.31M	190.23M	239.64M	277.97M	483.49M	1.41B
Gross Margin	76.57%	77.53%	78.52%	76.43%	79.73%	83.14%
Operating Income	-367.16M	-478.12M	-680.93M	-786.57M	-994.78M	-526.12M
Net Income	-434.65M	-481.53M	-749.57M	-913.77M	-1.28B	-561.31M
EPS	-	-	-	-	-6.42	-2.59
Free Cash Flow	-181.08M	-199.98M	-384.98M	-418.30M	-564.05M	-447.65M
No. Analysts	-	-	-	-	-	21

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	1.8B
Avg	1.7B
Low	1.6B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	200.1%
Avg	180.5%
Low	169.7%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-1.60
Avg	-2.59
Low	-4.29

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-